Employer | Amount |
---|---|
WA ST CHAPTER OF ASSOC PUBLIC SAFETY COMMUNICATIONS OFFICIALS | 113.00 |
LEADINGAGE WA | 113.00 |
GILEAD SCIENCES INC | 113.00 |
CONSUMER HEALTHCARE PRODUCTS ASSN | 113.00 |
bluebird bio, Inc. | 113.00 |
$0.00
Employer | Amount |
---|---|
WA ST CHAPTER OF ASSOC PUBLIC SAFETY COMMUNICATIONS OFFICIALS | 2000.00 |
UCB, INC | 4000.00 |
PARTNERS IN CAREERS | 1500.00 |
Orexo US, Inc. | 5000.00 |
LEADINGAGE WA | 7500.00 |
GILEAD SCIENCES INC | 4500.00 |
CONSUMER HEALTHCARE PRODUCTS ASSN | 4000.00 |
COASTAL CONSERVATION ASSN WA | 4000.00 |
bluebird bio, Inc. | 4000.00 |
No payments to sub-contracted lobbyists reported for April, 2019
No itemized entertainment expenses reported for April, 2019
No non-itemized entertainment expenses reported for April, 2019
No itemized contributions by employer reported for April, 2019
No itemized contributions by employer's PAC reported for April, 2019
No other itemized contributions reported for April, 2019
No non-itemized contributions by employer reported for April, 2019
0.00
No PAC contribution activity reported for April, 2019
No advertising expenses reported for April, 2019
No political advertising expenses reported for April, 2019
No other lobbying expenses reported for April, 2019
Employer | Subject Matter of Proposed Legislation | Issue or bill number | Persons, Legislative committee or State Agency considering the matter |
---|---|---|---|
WA ST CHAPTER OF ASSOC PUBLIC SAFETY COMMUNICATIONS OFFICIALS | Local government | SB 5272 Local Sale & Use Tax 911 | House Finance Committee |
UCB, INC | Health Care | HB 1224 Rx Transparency | House and Senate Health Care Committees |
PARTNERS IN CAREERS | Human services | Career Connected Learning | House and Senate Fiscal Committees |
Orexo US, Inc. | Health Care | Opioid Treatment | House and Senate Health Care Committees |
LEADINGAGE WA | Health Care | Long Term Care Funding / CCRC Disclosure | House and Senate Fiscal Committees / House and Senate Health Care |
GILEAD SCIENCES INC | Health Care | HB 1224 Rx Transparency | House and Senate Health Care |
CONSUMER HEALTHCARE PRODUCTS ASSN | Environmental Affairs - natural resources - parks | Plastic Packaging Stewardship | House and Senate Environment Committees |
COASTAL CONSERVATION ASSN WA | Environmental Affairs - natural resources - parks | Gillnet Ban and WDFW License Fess | House and Senate Natural Resources and Fiscal Committees |
bluebird bio, Inc. | Health Care | HB 1869 Emerging Therapies and Newborn Screening Funding | House and Senate Health Care and Fiscal Committees |
90.00%
Percent of time spent lobbying state agencies.10.00%